Plasma and salivary amoxicillin concentrations and effect against oral microorganisms

International Journal of Clinical Pharmacology and Therapeutics

Volumn 45, Issue 10, 2007, Pages 556-562

  Baglie, S ^a   Del Bortolo Ruenis, A P ^b   Lopes Motta, R H ^c   Catelli Baglie, R C ^b   Nobre Franco, G C ^b   Franco, L M ^d   Rosalen, P L ^b   Silva, P ^e   Groppo, F C ^b  

^a STATE UNIVERSITY OF PONTA GROSSA   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c SÃO LEOPOLDO MANDIC INSTITUTE AND RESEARCH CENTER   (Brazil)

^d METHODIST UNIVERSITY OF PIRACICABA   (Brazil)

^e Bioagri Laboratories Ltda   (Brazil)

Author keywords

Amoxicillin; Microorganism; Pharmacokinetics; Plasmatic concentration; Saliva

Indexed keywords

AMOXICILLIN; CEFADROXIL;

ADULT; ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG SALIVA LEVEL; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; MOUTH FLORA; NORMAL HUMAN; OPEN STUDY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS; TIME TO MAXIMUM PLASMA CONCENTRATION; VOLUNTEER;

EID: 34948813706     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP45556     Document Type: Article

References (40)

1. Agarwal G, Awasthi S, Kabra SK, Kaul A, Singhi S, Walter SD for the Iscap Study Group. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. BMJ. 2004; 3: 791.
2. Axelsson P, Lindhe J, Nystrom B. On the prevention of caries and periodontal disease. Results of a 15-year longitudinal study in adults. J Clin Periodontol. 1991; 18: 182-189.
3. Baglie S, Rosalen PL, Franco LM, Ruenis AP, Baglie RC, Franco GC et al. Comparative bioavailability of 875 mg amoxicillin tablets in healthy human volunteers. Int J Clin Pharmacol Ther. 2005; 43: 350-354.
4. Bantar C, Nicola F,, Fernandez Canigia L, Arenoso HJ, Soutric J, Montoto M et al. Rationale for treating community-acquired lower respiratory tract infections with amoxicillin/sulbactam combination through pharmacodynamic analysis in the setting of aminopenicillin-resistant organisms. J Chemother. 2001; 13: 402-406.
5. Baumgartner JC, Xia T. Antibiotic susceptibility of bacteria associated with endodontic abscesses. J Endod. 2003; 29: 44-47.
6. Beighton D, Hellyer PH, Lynch EJ, Heath MR. Salivary levels of mutans streptococci, lactobacilli, yeasts, and root caries prevalence in non-institutionalized elderly dental patients. Community Dent Oral Epidemiol. 1991; 19: 302-307.
7. Beikler T, Prior K, Ehmke B, Flemmig TF. Specific antibiotics in the treatment of periodontitis - a proposed strategy. J Periodontol. 2004; 75: 169-175.
8. Bowden GH. Mutans streptococci caries and chlorhexidine. J Can Dent Assoc. 1996; 62: 703-707.
9. Brook I. Microbiology and management of endodontic infections in children. J Clin Pediatr Dent. 2003; 28: 13-17.
10. Brundusino A, Lopes HV, Coelho DSB, Oliani C. Randomized crossover pharmacokinetic study with two oral amoxicillin pharmaceutical forms (tablets and capsules) at three different dosages. Eur Bull Drug Res. 1999; 7: 5-10.
11. Carlqvist J, Westerlund D. Automated determination of amoxycillin in biological fluids by column switching in ion-pair reversed-phase liquid chromatographic systems with post-column derivatization. J Chromatogr. 1985; 344: 285-296.
12. Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Clin Infect Dis. 1997; 25: 1448-1458.
13. Dhaon NA. Amoxicillin tablets for oral suspension in the treatment of acute otitis media: a new formulation with improved convenience. Adv Ther. 2004; 21: 87-95.
14. Garbutt JM, Goldstein M, Gellman E, Shannon W, Littenberg B. A randomized, placebo-controlled trial of antimicrobial treatment for children with clinically diagnosed acute sinusitis. Pediatrics. 2001; 107: 619-625.
15. Georgopoulos A, Borek M, Ridl W. Amoxycillin Bronchitis Study Group. Randomized, double-blind, double-dummy study comparing the efficacy and safety of amoxycillin 1 g bd with amoxycillin 500 mg tds in the treatment of acute exacerbations of chronic bronchitis. J Antimierob Chemother. 2001; 47: 67-76.
16. Goddard AF, Jessa MJ, Barrett DA, Shaw PN, Idstrom JP, Cederberg C et al. Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice. Gastroenterology. 1996; 111: 358-367.
17. Groppo FC, Ramacciato JC, Simoes RP, Florio FM, Sartoratto A. Antimicrobial activity of garlic, tea tree oil, and chlodaexidine against oral microorganisms. Int Dent J. 2002; 52: 433-437.
18. Jacinto RC, Gomes BP, Shah HN, Ferraz CC, Zaia AA, Souza-Filho FJ Incidence and antimicrobial susceptibility of Porphyromonas gingivalis isolated from mixed endodontic infections. Int Endod J. 2006; 39: 62-70.
19. Khemaleelakul S, Baumgartner JC, Pruksakorn S. Identification of bacteria in acute endodontic infections and their antimicrobial susceptibility. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002; 94: 746-755.
20. Lan AJ, Colford JM, Colford JM Jr. The impact of dosing frequency on the efficacy of 10-day penicillin or amoxicillin therapy for streptococcal tonsillopharyngitis: A meta-analysis. Pediatrics. 2000; 105: E19.
21. Langan CE, Cranfield R, Breisch S, Pettit R. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis. J Antimicrob Chemother. 1997; 40: 63-72.
22. MacGregor AJ, Hart P. The effect of a single large dose of amoxycillin on oral streptococci. J Antimicrob Chemother. 1986; 18: 113-117.
23. Mangiaracina G. Salivary elimination of amoxicillin after oral administration. G Stumatol Ortognatodonzia. 1984; 3: 681-682.
24. Marsh PD. Microbiologic aspects of dental plaque and dental caries. Dent Clin North Am. 1999; 43: 599-614.
25. Namiot Z, Namiot DB, Kemona A, Stasiewicz J. Effect of antibacterial therapy and salivary secretion on the efficacy of Helicobacter pylori eradication in duodenal ulcer patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004; 98: 714-717.
26. Oliveira CH, Abib E, Vannuchi YB, Sucupira M, Ilha J, De Nucci G. Comparative bioavailability of 4 amoxicillin formulations in healthy human volunteers after a single dose administration. Int J Clin Pharmacol Ther. 2001; 39: 167-172.
27. Ortiz RA, Calafatti SA, Corazzi A, Souza JM, Deguer M, De Souza CA et al. Amoxicillin and ampicillin are not transferred to gastric juice irrespective of Helicobacter pylori status or acid blockade by omeprazole. Aliment Pharmacol Ther. 2002; 16: 1163-1170.
28. Perez-Trallero E, Alkorta M, Garcia-Arenzana JM, Iturzaeta A, Gomariz M. In-vitro, in-vivo and ex-vivo studies with oral beta-lactams against Streptococcus pneumoniac. J Antimicrob Chemother. 1998; 41: 629-634.
29. Pires de Abreu LR, Ortiz RM, de Castro SC, Pedrazzoli J Jr. HPLC determination of amoxicillin comparative bioavailability in healthy volunteers after a single dose administration. J Pharm Pharm Sci. 2003; 6: 223-230.
30. Sborclone L, Barone A, Ramaglia L, Ciaglia RN, Iacono VJ. Antimicrobial susceptibility of periodontopathic bacteria associated with failing implants. J Periodontol. 1995; 66: 69-74.
31. Smith AJ, Jackson MS. Susceptibility of viridans group streptococci isolated from dento-alveolar infectious to eight antimicrobial agents. J Antimicrob Chemother. 2003; 52: 1045-1046.
32. Spangler SK, Lin G Jacobs MR, Appelbaum PC. Postantibiotic effect of sanfetrinem compared with those of six other agents against 12 penicillin-susceptible and -resistant pneumococci. Antimicrob Agents Chemother. 1997; 41: 2173-2176.
33. Sutter VL, Jones MJ, Ghoneim ATM. Antimicrobial susceptibility of bacteria associated with periodontal disease. Antimicrob Agents Chemother. 1983; 23: 483-486.
34. Thorburn CE, Knott SJ, Edwards DI. In vitro activities of oral beta-lactams at concentrations achieved in humans against penicillin-susceptible and -resistant pneumococci and potential to select resistance. Antimicrob Agents Chemother. 1998; 42: 1973-1979.
35. Tuohy M, Washington JA Antimicrobial susceptibility of viridans group streptococci. Diagn Microbiol Infect Dis. 1997; 29: 277-280.
36. Van der Velden U, Van Winkelhoff AJ, Abbas F, De Graaff J. The habitat of periodontopathic micro-organisms. J Clin Periodontol. 1986; 13: 243-248.
37. Wahl MJ, Pallasch TJ. Dentistry and Endocarditis. Cur-rent Infectious Disease Reports. 2005; 7: 251-256.
38. Walker C, Karpinia K. Rationale use of antibiotics in periodontics. J Periodontol. 2002; 73: 1188-1196.
39. Walker CB, Pappas JD, Tyler KZ, Cohen S, Gordon JM. Antimicrobial susceptibilities of periodontal bacteria. J Periodontol. 1985; 56: 67-74.
40. Yocum RR, Rasmussen JR, Strominger JL. The mechanism of action of penicillin. Penicillin aeylates the active site of Bacillus stearothermophilus D-alanine earboxypeptidase. J Biol Chem. 1980; 255: 3977-3986.